{
  "company": {
    "name": "VantAI",
    "website": "https://vant.ai/",
    "record": "https://startuphistory.org/c/vant.ai"
  },
  "status": null,
  "history_since": "2026-11-06T21:31:27.185Z",
  "baseline": null,
  "live_captures": 1,
  "last_checked": "2026-11-06T21:31:27.185Z",
  "live_status": null,
  "messaging": [],
  "changes": [],
  "update": null,
  "same_space": [
    {
      "name": "Proxima",
      "record": "https://startuphistory.org/c/proximabio.com",
      "basis": "ai_judged",
      "category": null,
      "overlap": "direct",
      "why": "Both use AI to design programmable proximity-based medicines targeting protein interactions for pharma partners."
    },
    {
      "name": "TernaryTx",
      "record": "https://startuphistory.org/c/ternarytx.co.uk",
      "basis": "ai_judged",
      "category": null,
      "overlap": "direct",
      "why": "Both apply AI to discover molecular glue and proximity-based small-molecule drugs for undruggable protein targets."
    },
    {
      "name": "Protai",
      "record": "https://startuphistory.org/c/protai.bio",
      "basis": "ai_judged",
      "category": null,
      "overlap": "partial",
      "why": "Both use AI and proteomics-focused platforms to discover novel therapeutics and drug targets."
    },
    {
      "name": "Chai Discovery",
      "record": "https://startuphistory.org/c/chaidiscovery.com",
      "basis": "ai_judged",
      "category": null,
      "overlap": "partial",
      "why": "Both use frontier AI to predict and engineer molecular interactions for therapeutic discovery."
    }
  ],
  "method": {
    "version": "messaging-v1",
    "description": "https://startuphistory.org/method"
  },
  "license": "CC-BY-4.0",
  "cite": "StartupHistory, “VantAI” company record, https://startuphistory.org/c/vant.ai"
}